KERAL Film-coated tablet Ref.[7936] Active ingredients: Dexketoprofen

Source: Medicines Authority (MT)  Revision Year: 2023  Publisher: Menarini International Operations Luxembourg S.A., 1, Avenue de la Gare, L-1611, Luxembourg

Product name and form

Keral 25 mg film-coated tablets.

Pharmaceutical Form

Film coated tablet.

White, round, scored film-coated tablet, with convex sides. The tablets can be divided into equal doses.

Qualitative and quantitative composition

Each tablet contains: dexketoprofen 25 mg as dexketoprofen trometamol.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Dexketoprofen

Dexketoprofen belongs to the non-steroidal anti-inflammatory group of drugs. The mechanism of action of Dexketoprofen is related to the reduction of prostaglandin synthesis by the inhibition of cyclooxygenase pathway. Furthermore, the inhibition of the synthesis of prostaglandins could affect other inflammation mediators such as kinins, causing an indirect action which would be additional to the direct action.

List of Excipients

Tablet core:

Maize starch
Microcrystalline cellulose
Sodium starch glycollate
Glycerol distearate

Film-coating:

Dry laquer composed of:

Hypromellose
Titanium dioxide
Macrogol 6000

Propylene glycol

Pack sizes and marketing

Tablets are provided in blister packs (PVC-aluminium blister or Aclar-aluminium blister or aluminium-aluminium blister).

Keral 25 mg tablets – 4, 10 or 20 film-coated tablets/pack.

Keral 25 mg tablets – 30, 50 or 500 film-coated tablets/pack.

Not all pack sizes may be marketed.

Marketing authorization holder

Menarini International Operations Luxembourg S.A., 1, Avenue de la Gare, L-1611, Luxembourg

Marketing authorization dates and numbers

Keral 25 mg tablets, 10 or 20 film-coated tablets – MA204/00107
Keral 25 mg tablets, 30, 50 or 500 film-coated tablets – MA204/00101

MA204/00101:

Date of first authorisation: 21st March 2006
Date of latest renewal: 29th July 2006

MA204/00107:

Date of first authorisation: 27th September 2013

Drugs

Drug Countries
KERAL Ireland, Malta, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.